CGNT - Cognyte Software Ltd. Stock Analysis | Stock Taper
Logo
Cognyte Software Ltd.

CGNT

Cognyte Software Ltd. NASDAQ
$9.67 -0.05% (-0.01)

Market Cap $706.28 M
52w High $11.65
52w Low $6.29
P/E -966.50
Volume 959.64K
Outstanding Shares 73.04M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2026 $106.24M $72.17M $3.76M 3.54% $0.05 $6.63M
Q3-2026 $100.74M $69.84M $-4.88M -4.85% $-0.07 $4.86M
Q2-2026 $97.51M $67.02M $1.47M 1.51% $0.02 $4.48M
Q1-2026 $95.55M $65.99M $-981K -1.03% $-0.01 $7.12M
Q4-2025 $94.5M $66.34M $-1.23M -1.3% $-0.02 $3.03M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2026 $116.88M $521.07M $292.2M $206.54M
Q3-2026 $106.59M $514.9M $287.38M $204M
Q2-2026 $84.48M $487.95M $262.88M $203.02M
Q1-2026 $102.64M $491.5M $275.7M $195.13M
Q4-2025 $112.72M $497.82M $280.72M $198.19M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2026 $3.76M $21.72M $-2.5M $-9.58M $10.29M $19.19M
Q3-2026 $-3.38M $24.97M $-1.65M $-1.34M $22M $22.78M
Q2-2026 $1.47M $-6.32M $-6.31M $-5.83M $-18.25M $-8.37M
Q1-2026 $142K $1.71M $-4.04M $-9.02M $-10.07M $-2.46M
Q4-2025 $-216K $18.69M $-3.05M $-7.95M $7.01M $14.43M

Revenue by Products

Product Q2-2013Q3-2013Q1-2014Q2-2014
Industrial
Industrial
$0 $0 $0 $0
Medical
Medical
$0 $0 $0 $0
Consolidated
Consolidated
$0 $0 $0 $0

Revenue by Geography

Region Q1-2016
All Other Foreign Countries
All Other Foreign Countries
$0
UNITED STATES
UNITED STATES
$20.00M

Q4 2026 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Cognyte Software Ltd.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Cognyte combines a strong strategic position in a specialized, mission‑critical analytics niche with very attractive gross margins, solid operating cash generation, and a conservative balance sheet featuring net cash and healthy liquidity. Its technology stack—anchored by AI‑driven platforms like NEXYTE and LUMINAR—and deep domain knowledge create high switching costs and trusted relationships with government and security‑focused customers. Significant R&D investment, a growing focus on recurring and SaaS revenue, and management’s expectations for continued revenue growth and improving margins all point to meaningful upside potential if the company continues to execute well.

! Risks

Key risks include a history of cumulative losses and a recent record of near break‑even net income, indicating that the economic model is not yet consistently translating strong gross margins into solid bottom‑line profits. High operating expenses, particularly in R&D and overhead, along with a sizeable goodwill balance, raise the stakes on successful growth and integration. Competitive pressure from larger analytics and security players, exposure to government procurement cycles and policy changes, and the fast‑moving nature of AI and data analytics all add uncertainty. Execution risk around the shift to a SaaS and recurring revenue model, as well as around international expansion efforts, is also significant.

Outlook

The overall outlook appears cautiously constructive: Cognyte has many of the ingredients of a durable, high‑quality software business—strong gross margins, robust cash flow, a net cash balance sheet, differentiated technology, and a clear niche—yet must still prove that it can deliver sustained, scalable profitability. If management can maintain revenue growth, expand margins as indicated, deepen recurring revenues, and keep innovating ahead of competitors, the company could gradually convert its strategic position into healthier earnings and stronger equity. However, the path forward is not guaranteed and will depend on consistent execution in a complex, regulated, and highly competitive environment, so future performance may be uneven even if the long‑term direction is positive.